Summary of findings table ‐ Emicizumab prophylaxis vs on‐demand therapy
Proportion with zero bleeds · people with inhibitors
Summary of findings table ‐ Emicizumab prophylaxis probably leads to higher proportion with zero bleeds compared with on‐demand therapy (moderate certainty).
1 finding from 1 review
- Non‐clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B 2024 · Cochrane Headline outcomes onlyRR 11.31 [1.66, 77.3]1 study · 53 participantsModerate